Technology Spotlight at UBD-Snibe Symposium 2026

best viewed on desktop

last updated 02/06/2026

.

contact informationubdsnibe2026@ubd.edu.bn

Symposium Theme: Advances in Clinical Chemistry & Immunoassay Technologies

20 - 21 June 2026

Beyond Automation Towards Excellence: Advancing Laboratory Diagnostics Through Innovation

The technology spotlight session explores how advances in laboratory diagnostics are supporting healthcare systems in addressing some of today's most significant population health challenges. As demands for accurate, efficient and timely diagnostic testing continue to grow, modern immunoassay technologies play an increasingly important role in supporting clinical decision-making, disease monitoring and patient care.

Presented by Snibe, the session will examine how innovations within the MAGLUMI immunoassay portfolio contribute to enhanced laboratory performance, workflow optimisation and diagnostic excellence. Through selected examples and practical applications, participants will gain insight into how contemporary laboratory technologies can support evolving healthcare needs while maintaining analytical quality and operational efficiency.

Snibe MAGLUMI Series

Important Dates

Abstract submission is extended and closes on Sunday, 31 May 2026. Click [here] for abstract guidelines.

Registration closes on Friday, 12 June 2026. Click [here] to reach the registration page.

Session Focus

The presentation will introduce the MAGLUMI portfolio, including the MAGLUMI X3, X6, X8 and X10 chemiluminescence immunoassay (CLIA) systems. The session will highlight key developments in automated immunoassay testing and discuss how diagnostic innovation can support laboratories in responding to major health concerns affecting modern populations.

The MAGLUMI X3 analyser will be featured on display during the session as an example of current-generation immunoassay technology.

Facilitator

Janice Ong Joe Hui, Snibe

Format

This technology spotlight is presentation-based and designed to provide an educational overview of current developments in diagnostic technology. The emphasis will be on:

  • Expert-led explanation of platform technology
  • Demonstration of system capabilities
  • Case-based illustration using real laboratory data
  • Q&A engagement

Following the presentation, attendees will have the opportunity to view the MAGLUMI X3 analyser on stage and engage directly with the facilitator.

Learning Value

Participants will gain insight into:

  • Current developments in immunoassay tehcnology
  • The role of automated  CLIA platforms in routine laboratory workflows
  • Practical considerations in assay performance, workflow optimisation and system integration
  • The broader impact of diagnostic innovation on laboratory efficiency and patient care

Who Should Attend

This session is suitable for:

  • Biomedical science and health science students
  • Laboratory professionals and clinical scientists
  • Academic staff and researchers
  • Individuals interested in clinical chemistry and diagnostic technologies

Disclaimer

The display, presentation and demonstration of any diagnostic platforms during the symposium does not constitute an endorsement of such platforms by Universiti Brunei Darussalam.